CME Activity Credit Expired

CME Info

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Dover Communications. PIM is accredited by the ACCME to provide continuing medical education for physicians.

CME Credit

Postgraduate Institute for Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty Disclosures

Richard J. Derman, MD, MPH, FACOG
Grants/Research Support: Procter & Gamble; Roche Pharmaceuticals
Consultant: Merck & Co., Inc.; Procter & Gamble; Roche Pharmaceuticals; Wyeth Pharmaceuticals
Speakers' Bureau: Merck & Co., Inc.; Procter & Gamble; Roche Pharmaceuticals; Solvay Pharmaceuticals; Wyeth Pharmaceuticals

Risa Kagan, MD, FACOG
Grants/Research Support: Aventis Pharmaceuticals Inc; Eli Lilly and Company; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Procter & Gamble; Wyeth Pharmaceuticals
Consultant: Aventis Pharmaceuticals Inc; Eli Lilly and Company; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Procter & Gamble; Wyeth Pharmaceuticals
Speakers' Bureau: Merck & Co., Inc.; Procter & Gamble

James A. Simon, MD
Grants/Research Support: Abbott Laboratories; Amgen Inc; Aventis Pharmaceuticals Inc; Barr Laboratories; Bayer Pharmaceuticals Corporation; Berlex Laboratories; Besins Laboratories; BioSante Pharmaceuticals; Bristol-Myers Squibb Company; Duramed Pharmaceuticals Inc; Galen Institute; Eli Lilly and Company; 3M Pharmaceuticals; Merck & Co., Inc.; National Institutes of Health; Novartis Pharmaceuticals Corporation; Novavax, Inc.; Organon USA, Inc.; Ortho-McNeil Pharmaceutical, Inc; Pfizer Inc; Procter & Gamble; Solvay Pharmaceuticals; TAP Pharmaceuticals; Upsher-Smith Laboratories Inc.; Vivus, Inc.; Watson Pharmaceuticals, Inc.; Wyeth Pharmaceuticals
Consultant: Abbott Laboratories; Barr Laboratories; Berlex Laboratories; BioSante Pharmaceuticals; Duramed Pharmaceuticals Inc; Galen Institute; GlaxoSmithKline; Johnson & Johnson; Lipocine, Inc.; Merck & Co., Inc.; Merrion Pharmaceuticals; Novavax, Inc.; Noven Pharmaceuticals Inc; Pfizer Inc; Procter & Gamble; Roche Pharmaceuticals; Solvay Pharmaceuticals; TAP Pharmaceuticals; Vivus, Inc.; Wyeth Pharmaceuticals
Speakers' Bureau: Abbott Laboratories; Aventis Pharmaceuticals Inc; Berlex Laboratories; Eli Lilly and Company; Merck & Co., Inc.; Ortho Biotech Products, L.P.; Pfizer Inc; Solvay Pharmaceuticals; Wyeth Pharmaceuticals